XML 45 R39.htm IDEA: XBRL DOCUMENT v3.24.3
Collaboration Agreements, License Agreement and Revenues - Roll-forward of Related Contract Liabilities (Detail)
$ in Thousands
9 Months Ended
Sep. 30, 2024
USD ($)
AstraZeneca Agreements [Member]  
Contract with Customer Liability [Line Items]  
Balance at December 31, 2023 $ (179,851)
Additions (82,185)
Recognized as Revenue 115,339
Currency Translation and Other (270)
Balance at September 30, 2024 (146,967)
Drug Product Revenue, Net [Member] | Astellas Agreement [Member] | Europe [Member]  
Contract with Customer Liability [Line Items]  
Balance at December 31, 2023 (16,925)
Reclassified to Accrued Liability 5,605
Recognized as Revenue 3,210
Balance at September 30, 2024 $ (8,110)